Cyclic sulfamide compounds and methods of using same
US11078170B2 · kind B2 · utility
0Cited by
7References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 1, 2018 |
| Grant date | Aug 3, 2021 |
| Priority date | — |
| Expiry date | Mar 1, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure provides, in part, cyclic sulfamide compounds, and pharmaceutical compositions thereof, useful as modulators of Hepatitis B (HBV) core protein, and methods of treating Hepatitis B (HBV) infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.